免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

ALLY自适应白内障治疗系统

K号: K220259 · 2022-06-09

申请人Lensar, Inc.
决定日期2022-06-09
产品代码OOE
咨询委员会OP 请注意,由于您没有提供具体的医疗设备监管文本,我无法进行翻译。请提供具体的文本内容,以便我能够按照您的要求进行翻译。
决定实质等同

器械摘要

ALLY Adaptive Cataract Treatment System is the device name listed in this FDA 510(k) record. The listed applicant is Lensar, Inc.. It received FDA 510(k) clearance on 2022-06-09 under 510(k) number K220259. The device is classified under product code OOE. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the ALLY Adaptive Cataract Treatment System?

ALLY Adaptive Cataract Treatment System is a medical device that received FDA 510(k) clearance on 2022-06-09. The listed applicant is Lensar, Inc.. The 510(k) number is K220259.

When did ALLY Adaptive Cataract Treatment System receive FDA 510(k) clearance?

ALLY Adaptive Cataract Treatment System received FDA 510(k) clearance on 2022-06-09, under 510(k) number K220259.

Who is the listed applicant for ALLY Adaptive Cataract Treatment System?

The FDA 510(k) record lists Lensar, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ALLY Adaptive Cataract Treatment System?

The FDA product code for ALLY Adaptive Cataract Treatment System is OOE.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Lensar, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:OOE)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑